Dr. Mikhail Blagosklonny is an Oncology Professor at the Rosewell Park Cancer Institute. He has devoted his life to researching cancer and a variety of treatments for this devastating disease. Among other work, he has advocated the use of Rapamycin to increase human longevity. Rapamycin was first isolated in 1972 from a bacterium. When it was first discovered, scientists used it to make an anti-fungal treatment. Subsequently, it was discovered that this drug could be used to fight a variety of diseases. It is also currently being researched as a treatment for more illnesses.
One of Rapamycin’s most famous uses is as an immunosuppressant. In this use, it can help an organ transplant procedure be a success by helping the patient’s body accept the organ. Many drugs used for this purpose negatively affect the kidneys. However, Rapamycin is less toxic on the kidneys. It can also be used to treat different lung diseases. Another major use of this drug is as a coating for stents. This is done to prevent an artery from becoming blocked again following an angioplasty procedure. Patients with a Rapamycin coating take longer to form blockages in the same area.
Another important use of Rapamycin is in cancer treatments. Taken in appropriate doses, this drug can enhance a body’s immune response towards tumors. Patients who have transplanted organs can lower their risk of cancer by taking this drug. Dr. Mikhail Blagosklonny is researching the possibilities of using this drug to increase a person’s lifespan. This research is still ongoing. Other ongoing Rapamycin research include its use in the treatment of Alzheimer’s, Muscular Dystrophy and Systemic Lupus Erythematosus.
Dr. Blagosklonny also has plans for the future of Onocology and cancer treatments. His present focus is trying to determine why cancer is seen more often in older people. This ties into his research in increasing the human lifespan. He also tries to inspire future researchers to continue his work. Dr. Blagosklonny is interested in finding ways to treat cancer more cost effectively. His goal is for cancer treatment to become an easily afforded thing instead of a luxury.
Another part of Dr. Blagosklonny’s work focuses on make cancer treatments less painful. Current cancer treatments kill normal body cells that could help a person recover quicker. Dr. Blagosklonny hopes to find a treatment that can kill cancer cells without damaging normal cells. He has made progress in this area and hopes that other researchers will expand upon and continue his work.
Mikhail Blagosklonny is an Oncologist who is working to improve and extend the lives of humans. He has conducted and continues to conduct fascinating research aimed at improving cancer treatments and making them more affordable. He also works with innovative drugs, like Rapamycin, to find new ways they can help people.